vs

Side-by-side financial comparison of COHERENT CORP. (COHR) and Edwards Lifesciences (EW). Click either name above to swap in a different company.

COHERENT CORP. is the larger business by last-quarter revenue ($1.7B vs $1.6B, roughly 1.0× Edwards Lifesciences). Edwards Lifesciences runs the higher net margin — 23.1% vs 8.7%, a 14.4% gap on every dollar of revenue. On growth, COHERENT CORP. posted the faster year-over-year revenue change (17.5% vs 16.7%). Over the past eight quarters, COHERENT CORP.'s revenue compounded faster (18.1% CAGR vs 9.7%).

Coherent Corp. is an American manufacturer of optical materials and semiconductors. As of 2023, the company had 26,622 employees. Their stock is listed at the New York Stock Exchange under the ticker symbol COHR. In 2022, II-VI acquired laser manufacturer Coherent, Inc., and adopted its name.

Edwards Lifesciences Corporation is an American medical technology company headquartered in Irvine, California, specializing in artificial heart valves and hemodynamic monitoring. It developed the Sapien transcatheter aortic heart valve made of cow tissue within a balloon-expandable, cobalt-chromium frame, deployed via catheter.

COHR vs EW — Head-to-Head

Bigger by revenue
COHR
COHR
1.0× larger
COHR
$1.7B
$1.6B
EW
Growing faster (revenue YoY)
COHR
COHR
+0.8% gap
COHR
17.5%
16.7%
EW
Higher net margin
EW
EW
14.4% more per $
EW
23.1%
8.7%
COHR
Faster 2-yr revenue CAGR
COHR
COHR
Annualised
COHR
18.1%
9.7%
EW

Income Statement — Q2 FY2026 vs Q1 FY2026

Metric
COHR
COHR
EW
EW
Revenue
$1.7B
$1.6B
Net Profit
$146.7M
$380.7M
Gross Margin
36.9%
78.0%
Operating Margin
10.0%
1.8%
Net Margin
8.7%
23.1%
Revenue YoY
17.5%
16.7%
Net Profit YoY
41.9%
6.8%
EPS (diluted)
$0.76
$0.66

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
COHR
COHR
EW
EW
Q1 26
$1.6B
Q4 25
$1.7B
$1.6B
Q3 25
$1.6B
$1.6B
Q2 25
$1.5B
$1.5B
Q1 25
$1.5B
$1.4B
Q4 24
$1.4B
$1.4B
Q3 24
$1.3B
$1.4B
Q2 24
$1.3B
$1.4B
Net Profit
COHR
COHR
EW
EW
Q1 26
$380.7M
Q4 25
$146.7M
$91.2M
Q3 25
$226.3M
$291.1M
Q2 25
$-95.6M
$333.2M
Q1 25
$15.7M
$358.0M
Q4 24
$103.4M
$385.6M
Q3 24
$25.9M
$3.1B
Q2 24
$-48.4M
$366.3M
Gross Margin
COHR
COHR
EW
EW
Q1 26
78.0%
Q4 25
36.9%
78.1%
Q3 25
36.6%
77.8%
Q2 25
35.7%
77.5%
Q1 25
35.2%
78.7%
Q4 24
35.5%
78.9%
Q3 24
34.1%
80.6%
Q2 24
32.9%
79.9%
Operating Margin
COHR
COHR
EW
EW
Q1 26
1.8%
Q4 25
10.0%
9.6%
Q3 25
13.7%
19.8%
Q2 25
-4.1%
26.8%
Q1 25
0.7%
27.9%
Q4 24
9.0%
22.6%
Q3 24
1.4%
25.9%
Q2 24
4.8%
26.8%
Net Margin
COHR
COHR
EW
EW
Q1 26
23.1%
Q4 25
8.7%
5.8%
Q3 25
14.3%
18.7%
Q2 25
-6.3%
21.7%
Q1 25
1.0%
25.3%
Q4 24
7.2%
27.8%
Q3 24
1.9%
226.7%
Q2 24
-3.7%
26.7%
EPS (diluted)
COHR
COHR
EW
EW
Q1 26
$0.66
Q4 25
$0.76
$0.16
Q3 25
$1.19
$0.50
Q2 25
$-0.81
$0.56
Q1 25
$-0.11
$0.61
Q4 24
$0.44
$0.65
Q3 24
$-0.04
$5.13
Q2 24
$-0.52
$0.61

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
COHR
COHR
EW
EW
Cash + ST InvestmentsLiquidity on hand
$863.7M
Total DebtLower is stronger
$3.4B
Stockholders' EquityBook value
$8.5B
Total Assets
$15.1B
Debt / EquityLower = less leverage
0.39×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
COHR
COHR
EW
EW
Q1 26
Q4 25
$863.7M
$4.2B
Q3 25
$852.8M
$3.8B
Q2 25
$909.2M
$4.1B
Q1 25
$890.3M
$3.9B
Q4 24
$917.8M
$4.0B
Q3 24
$1.0B
$4.4B
Q2 24
$926.0M
$2.0B
Total Debt
COHR
COHR
EW
EW
Q1 26
Q4 25
$3.4B
Q3 25
$3.3B
Q2 25
$3.7B
Q1 25
$3.7B
Q4 24
$3.9B
Q3 24
$4.0B
Q2 24
$4.1B
Stockholders' Equity
COHR
COHR
EW
EW
Q1 26
Q4 25
$8.5B
$10.3B
Q3 25
$5.8B
$10.2B
Q2 25
$5.6B
$10.5B
Q1 25
$5.4B
$10.1B
Q4 24
$5.2B
$10.0B
Q3 24
$5.5B
$9.5B
Q2 24
$5.2B
$7.4B
Total Assets
COHR
COHR
EW
EW
Q1 26
Q4 25
$15.1B
$13.7B
Q3 25
$14.7B
$13.3B
Q2 25
$14.9B
$13.5B
Q1 25
$14.4B
$13.0B
Q4 24
$14.2B
$13.1B
Q3 24
$14.7B
$13.0B
Q2 24
$14.5B
$10.1B
Debt / Equity
COHR
COHR
EW
EW
Q1 26
Q4 25
0.39×
Q3 25
0.57×
Q2 25
0.65×
Q1 25
0.70×
Q4 24
0.75×
Q3 24
0.73×
Q2 24
0.79×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
COHR
COHR
EW
EW
Operating Cash FlowLast quarter
$57.9M
Free Cash FlowOCF − Capex
$-95.7M
FCF MarginFCF / Revenue
-5.7%
Capex IntensityCapex / Revenue
9.1%
Cash ConversionOCF / Net Profit
0.39×
TTM Free Cash FlowTrailing 4 quarters
$-103.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
COHR
COHR
EW
EW
Q1 26
Q4 25
$57.9M
$450.9M
Q3 25
$46.0M
$573.7M
Q2 25
$130.3M
$290.2M
Q1 25
$163.0M
$280.4M
Q4 24
$187.4M
$-127.5M
Q3 24
$153.0M
$351.8M
Q2 24
$162.3M
$371.5M
Free Cash Flow
COHR
COHR
EW
EW
Q1 26
Q4 25
$-95.7M
$353.5M
Q3 25
$-58.0M
$516.2M
Q2 25
$-1.1M
$240.9M
Q1 25
$51.1M
$224.4M
Q4 24
$81.7M
$-177.3M
Q3 24
$61.0M
$299.9M
Q2 24
$62.4M
$286.1M
FCF Margin
COHR
COHR
EW
EW
Q1 26
Q4 25
-5.7%
22.5%
Q3 25
-3.7%
33.2%
Q2 25
-0.1%
15.7%
Q1 25
3.4%
15.9%
Q4 24
5.7%
-12.8%
Q3 24
4.5%
22.1%
Q2 24
4.7%
20.9%
Capex Intensity
COHR
COHR
EW
EW
Q1 26
Q4 25
9.1%
6.2%
Q3 25
6.6%
3.7%
Q2 25
8.6%
3.2%
Q1 25
7.5%
4.0%
Q4 24
7.4%
3.6%
Q3 24
6.8%
3.8%
Q2 24
7.6%
6.2%
Cash Conversion
COHR
COHR
EW
EW
Q1 26
Q4 25
0.39×
4.94×
Q3 25
0.20×
1.97×
Q2 25
0.87×
Q1 25
10.37×
0.78×
Q4 24
1.81×
-0.33×
Q3 24
5.91×
0.11×
Q2 24
1.01×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

COHR
COHR

Datacenter And Communications Segment$1.2B72%
Industrial Segment$477.7M28%

EW
EW

Segment breakdown not available.

Related Comparisons